Oracle's stock has fallen more than 30% from its peak. Oracle Corp.'s stock can reclaim its highs and then post even bigger gains from there, according to a Jefferies analyst.
A majority of early users say Oracle Health’s new Clinical AI Agent is reducing documentation time and easing clinician burnout, according to a Nov. 12 KLAS Research report. KLAS interviewed 17 ...
Logitech acknowledges being hit by a zero-day exploit that stole limited customer data that didn't include credit card ...
Finance operations platform BILL and ERP vendor NetSuite have souped up accounts payable capabilities via Agentic AI, ...
Zacks Investment Research on MSN
Oracle (ORCL) Falls More Steeply Than Broader Market: What Investors Need to Know
Oracle (ORCL) closed at $219.86 in the latest trading session, marking a -1.34% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.92%. Meanwhile, the Dow ...
Wall Street faces uncertainty post-shutdown, lacking key economic data. Learn more about the market here and what long-term ...
A boom in energy- and water-intensive data centers has opened a new era of confrontation between energy and water across the ...
Baron Funds, an investment management company, released its “Baron FinTech Fund” third-quarter 2025 investor letter. A copy ...
News from the week beginning 22nd September includes items from @Anybotics, @zoho, @planful, and @ThomsonReuters ...
Buster Posey and the Giants will look to make this a playoff-caliber roster. What do they need to bring in for that to happen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback